155 related articles for article (PubMed ID: 10520035)
1. The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment.
Rawstron AC; Rollinson SJ; Richards S; Short MA; English A; Morgan GJ; Hale G; Hillmen P
Br J Haematol; 1999 Oct; 107(1):148-53. PubMed ID: 10520035
[TBL] [Abstract][Full Text] [Related]
2. Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism.
Taylor VC; Sims M; Brett S; Field MC
Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):919-25. PubMed ID: 9148769
[TBL] [Abstract][Full Text] [Related]
3. Biological and molecular characterization of PNH-like lymphocytes emerging after Campath-1H therapy.
Fracchiolla NS; Barcellini W; Bianchi P; Motta M; Fermo E; Cortelezzi A
Br J Haematol; 2001 Mar; 112(4):969-71. PubMed ID: 11298593
[TBL] [Abstract][Full Text] [Related]
4. Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletion.
Garland RJ; Groves SJ; Diamanti P; West SE; Winship KL; Virgo PF; Robinson SP; Oakhill A; Cornish JM; Pamphilon DH; Marks DI; Goulden NJ; Steward CG
Bone Marrow Transplant; 2005 Aug; 36(3):237-44. PubMed ID: 15968291
[TBL] [Abstract][Full Text] [Related]
5. Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment.
Brett SJ; Baxter G; Cooper H; Rowan W; Regan T; Tite J; Rapson N
Int Immunol; 1996 Mar; 8(3):325-34. PubMed ID: 8671618
[TBL] [Abstract][Full Text] [Related]
6. CD55 and CD59 deficiency in transplant patient populations: possible association with paroxysmal nocturnal hemoglobinuria-like symptoms in Campath-treated patients.
Ruiz P; Weppler D; Tryphonopoulos P; Nishida S; Moon J; Kato T; Selvaggi G; Levi D; Madariaga J; DelaGarza J; Tuteja S; Garcia M; Tzakis A
Transplant Proc; 2006; 38(6):1750-2. PubMed ID: 16908271
[TBL] [Abstract][Full Text] [Related]
7. [Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment].
Röth A; Dührsen U; Schrezenmeier H; Schubert J
Dtsch Med Wochenschr; 2009 Feb; 134(9):404-9. PubMed ID: 19224425
[TBL] [Abstract][Full Text] [Related]
8. Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma.
Hertenstein B; Wagner B; Bunjes D; Duncker C; Raghavachar A; Arnold R; Heimpel H; Schrezenmeier H
Blood; 1995 Aug; 86(4):1487-92. PubMed ID: 7632956
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria.
Tseng JE; Hall SE; Howard TA; Ware RE
Am J Hematol; 1995 Dec; 50(4):244-53. PubMed ID: 7485098
[TBL] [Abstract][Full Text] [Related]
10. [Paroxysmal nocturnal hemoglobinuria].
Peffault de Latour R; Amoura Z; Socié G
Rev Med Interne; 2010 Mar; 31(3):200-7. PubMed ID: 19303177
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the PIG-A gene causing partial deficiency of GPI-linked surface proteins (PNH II) in patients with paroxysmal nocturnal haemoglobinuria.
Bessler M; Mason PJ; Hillmen P; Luzzatto L
Br J Haematol; 1994 Aug; 87(4):863-6. PubMed ID: 7986731
[TBL] [Abstract][Full Text] [Related]
12. Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
Nishimura Ji ; Phillips KL; Ware RE; Hall S; Wilson L; Gentry TL; Howard TA; Murakami Y; Shibano M; Machii T; Gilboa E; Kanakura Y; Takeda J; Kinoshita T; Rosse WF; Smith CA
Blood; 2001 May; 97(10):3004-10. PubMed ID: 11342424
[TBL] [Abstract][Full Text] [Related]
13. Frequent HPRT mutations in paroxysmal nocturnal haemoglobinuria reflect T cell clonal expansion, not genomic instability.
Chen G; Zeng W; Green S; Young NS
Br J Haematol; 2004 May; 125(3):383-91. PubMed ID: 15086421
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the diagnosis, monitoring, and management of patients with paroxysmal nocturnal hemoglobinuria.
Richards SJ; Hill A; Hillmen P
Cytometry B Clin Cytom; 2007 Sep; 72(5):291-8. PubMed ID: 17549742
[TBL] [Abstract][Full Text] [Related]
15. PIG-A gene mutations in four Taiwanese patients with paroxysmal nocturnal haemoglobinuria following aplastic anaemia.
Lin LI; Liu CH; Chen YC; Shen MC; Wang CH; Huang YL; Lin JK
Br J Haematol; 1997 May; 97(2):286-92. PubMed ID: 9163589
[TBL] [Abstract][Full Text] [Related]
16. ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 1 - clinical utility.
Dezern AE; Borowitz MJ
Cytometry B Clin Cytom; 2018 Jan; 94(1):16-22. PubMed ID: 29236352
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria.
Bessler M; Mason P; Hillmen P; Luzzatto L
Lancet; 1994 Apr; 343(8903):951-3. PubMed ID: 7909012
[TBL] [Abstract][Full Text] [Related]
18. Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.
Osterborg A; Dyer MJ; Bunjes D; Pangalis GA; Bastion Y; Catovsky D; Mellstedt H
J Clin Oncol; 1997 Apr; 15(4):1567-74. PubMed ID: 9193354
[TBL] [Abstract][Full Text] [Related]
19. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
Bessler M
Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
[TBL] [Abstract][Full Text] [Related]
20. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.
Rosti V; Tremml G; Soares V; Pandolfi PP; Luzzatto L; Bessler M
J Clin Invest; 1997 Sep; 100(5):1028-36. PubMed ID: 9276719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
